The FDA's push for lower-cost medicines looks good on paper, but the patent office under President Trump may be going in the ...
The U.S. Food and Drug Administration said on Friday it approved new labeling for Sarepta Therapeutics' gene therapy Elevidys ...
The Food and Drug Administration is adding a new warning to a gene therapy linked to two patient deaths earlier this year.
The U.S. Food and Drug Administration can approve new personalized treatments for rare and deadly genetic diseases based on ...
Health Secretary Robert F. Kennedy Jr. considered installing a new leader to manage the agency on a day-to-day basis.
According to an enforcement report from the Food and Drug Administration (FDA), Sun Pharmaceutical Industries Inc. initiated ...
MedPage Today on MSN
Here's What RFK Jr., FDA Got Wrong About Menopausal Hormone Therapy
Kennedy said hormone therapy could "reduce the risks of cardiovascular disease and mortality by as much as 50%, Alzheimer's ...
Sarepta Therapeutics Inc.’s controversial gene therapy for a rare muscle condition will remain available in the US with a ...
Broadcast Retirement Network's Jeffrey Snyder discusses Over-the-Counter hearing aids with Towson University's Julie Norin, AuD.
The U.S. Food and Drug Administration said on Tuesday it appointed the agency's veteran oncology chief Richard Pazdur to ...
The FDA has issued warning letters to over a dozen companies selling 'unapproved' brands of Botox and warns consumers of the ...
Eminent Spine, a leader in spinal implant innovation, proudly announces that its revolutionary 3D Printed Titanium Posterior SI System has received FDA 510(k) clearance as of October 7, 2025.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results